
News|Videos|May 25, 2023
Changing the Paradigms of How We Think About Depression
Author(s)Greg Mattingly, MD
Check out this review of the 2023 APA Annual Meeting presentation on the efficacy and safety of repeat treatment courses using novel medicine, zuranolone.
Advertisement
CONFERENCE REPORTER
Greg Mattingly, MD, shares a review of the 2023 APA Annual Meeting presentation that covered long term results of the year long study on zuranolone in major depressive disorder.
Dr Mattingly is an associate clinical professor at Washington University School of Medicine, and is a physician and principal investigator in clinical trials for Midwest Research Group.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Remlifanserin for the Treatment of Alzheimer Disease Psychosis Receives FDA Fast Track Designation
2
Targeting APOE4: A Promising Therapeutic Strategy for Alzheimer Disease
3
Future DSM Plans Overlook Core Problem of Validity
4
Classic Drug, New Target: Lithium as Disease-Modifying in Alzheimer Dementia
5









